Zhangjiagang two main port area two glycol total car shipments in the vicinity of 1070 tons.

Sinopec Sales Company of Shanghai petrochemical, Yangzi Petrochemical two glycol price 6300 yuan / ton, up 200 yuan / ton, inventory shipments normal, reasonable, normal operation of each business unit.

The operation of the Fushun Petrochemical two glycol device is normal, the implementation of the factory price of 6100 yuan / ton, enterprise recent shipment is not much, the main contract for households, 200 tons per month in normal level, sales.

Market summary: Recently, two DEG to the port inventory in decline in the channel, support shippers attitude, but after the surge of raw materials. Follow up on the floor of the downstream UPR recent intention to cool down, corporate profits substantially reduced, some enterprises choose delisting wait and see. In the short term is expected to two DEG or continue to pull up the situation.

at present, in the commodities continued to heat up, the national regulation is expected to be bad news late peripheral market, weak guidance.

Overview two glycol market of some areas in China in November 29th:

Jilin Petrochemical two glycol factory price 6100 yuan / ton, inventory is reasonable, for each other, part of the export, the normal operation of enterprises of ethylene glycol plant.

The operation of the Dushanzi Petrochemical two glycol device is normal, the implementation of the factory price of 6300 yuan / ton, price increase 200 yuan / ton, sales oriented enterprises in Xinjiang, the normal operation of equipment.

Qilu plasticizer DOP factory price down 50 yuan / ton price in 8650 yuan / ton.

LAN-STAR Harbin Petrochemical phthalic anhydride plant has been restarted, load increase, the current low inventory of goods, today temporarily quotations, real simple talks.

Wide DOP market in North China area of Tianjin higher level of cash supply tight, the market reference price of 8700 yuan / ton to discuss.

Market summary: at present, the domestic DOP terminal market demand is difficult to improve, the demand outlook is restrained, but the raw materials cost lead octanol and phthalic anhydride remained high, the fluctuation amplitude control. Expected short-term DOP market still has to continue to decline.

Also because of the practical reasons, the pollution problem and Chinese almost raw materials and generic pharmaceutical industry always parallel, can not find a fundamental solution to the.

Public data shows, in recent years, almost all enterprises are facing the embarrassment of antibiotics because of pollution problems are named fines, Harbin Pharmaceutical shares, federal pharmaceutical, pharmaceutical and large pharmaceutical companies have in the environmental protection department supervision rectification list. Even, some enterprises after rectification is also difficult to reach the standard, often “the list”, such as the federal pharmaceutical, since 2004 twelve years, has nine times by the environmental protection department criticized, limiting the production cuts or even shut down.

The pollution problems have been exposed in the case of Harbin, Harbin pharmaceutical company said in the announcement, “in recent years, the company has invested 400 million yuan for cleaner production and environmental management, mainly the construction of wastewater treatment and sewage treatment, odor, noise, etc. the boiler flue gas pollution treatment facilities. The annual operating costs of various environmental protection facilities in more than 5000 yuan.”

But even for the relocation to eradicate the pollution problem of investment, Harbin in its 2010 annual report also said pessimistically, due to different construction of huge investment, the added value of raw materials products is low, meager profit margins, is expected to put into operation after 2~3 years will not have a competitive advantage, so easily cause enterprises in a loss situation, causes the enterprise to survive the consequences”.

To gather a large number of pharmaceutical companies in the pharmaceutical city of Shijiazhuang, which means, including pharmaceutical, Shijiazhuang Pharmaceutical Group, North China Pharmaceutical and Yiling Pharmaceutical (17.340, -0.04, -0.23%) and other well-known domestic pharmaceutical companies will not return to work since the clear period frozen period”.

At present, the company mainly raw materials, products have a certain stock, short-term sales are not affected, but still can not determine the specific time in view of the production, the specific impact of the above matters of the company’s production and the results could not be predicted.” North China Pharmaceutical Bulletin pointed out.

“Environmental cost is too high, must be compliance will go bankrupt, which does not spend money, now these workers do?” A Shijiazhuang pharmaceutical companies responsible 22 said, “we have been upgrading these years some serious pollution of the old varieties, but the product transition is not three years five years can be replaced, and generic drugs varieties upgrade space is very limited.”

The production characteristics of pharmaceutical fermentation industry is the production of varieties, production processes, the use of various types of raw materials, large quantity, low utilization rate of raw materials. A general API often have several steps even ten steps, use of raw materials or several dozen, even as high as 30~40 for the “three wastes” in large quantity, complex composition of waste pollution serious damage.